Literature DB >> 29943890

Multi-ethnic comparisons of diabetes in heart failure with reduced ejection fraction: insights from the HF-ACTION trial and the ASIAN-HF registry.

Lauren B Cooper1,2, Jonathan Yap3, Wan Ting Tay3, Tiew-Hwa K Teng3, Michael MacDonald4, Inder S Anand5, Abhinav Sharma6,7, Christopher M O'Connor1,2, William E Kraus2, Robert J Mentz2, Carolyn S Lam3,8.   

Abstract

AIM: To describe differences in patient characteristics and outcomes by ethnicity in patients with diabetes mellitus (DM) and heart failure (HF) with reduced ejection fraction (HFrEF, ejection fraction ≤35%) in a multi-ethnic cohort. METHODS AND
RESULTS: Patient level data from two cohorts (HF-ACTION and ASIAN-HF) were combined, and patients grouped by self-reported ethnicity. DM was defined as the presence of a clinical diagnosis and/or receiving anti-diabetic therapy. A total of 6214 (1324 whites, 674 blacks, 1297 Chinese, 1510 Indians, 717 Malays, 692 Japanese/Koreans) patients were included. The overall prevalence of DM was 39.5% (n = 2454). The prevalence of DM was lowest in whites (29.3%), followed by Japanese/Koreans (34.1%), blacks (35.9%), Chinese (42.3%), Indians (44.2%), and highest in Malays (51.9%). The correlation between age, sex, body mass index, coronary artery disease, hypertension, atrial fibrillation, peripheral vascular disease and chronic kidney disease with DM differed significantly by ethnicity (P for interaction <0.05). The strongest correlations were seen in Malay women, whites with obesity, Indians with coronary artery disease and hypertension, and blacks with chronic kidney disease. On multivariable analyses, DM was significantly associated with the composite of 1-year overall mortality/HF hospitalization (hazard ratio 1.37, 95% confidence interval 1.19-1.57; P < 0.001), with no interaction by ethnicity (P for interaction =0.31).
CONCLUSIONS: There is marked heterogeneity in the prevalence and correlates of DM among different ethnic groups with HF worldwide. Subgroups particularly predisposed to DM warrant special attention, since DM increases the combined risk of morbidity and mortality in all ethnicities with HF.
© 2018 The Authors. European Journal of Heart Failure © 2018 European Society of Cardiology.

Entities:  

Keywords:  Diabetes mellitus; Ethnicity; Heart failure; Outcomes

Mesh:

Substances:

Year:  2018        PMID: 29943890     DOI: 10.1002/ejhf.1223

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  10 in total

Review 1.  Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence.

Authors:  Alberto Palazzuoli; Massimo Iacoviello
Journal:  Heart Fail Rev       Date:  2022-05-06       Impact factor: 4.654

2.  Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.

Authors:  Jonathan Yap; Wan Ting Tay; Tiew-Hwa Katherine Teng; Inder Anand; A Mark Richards; Lieng Hsi Ling; Michael R MacDonald; Chanchal Chandramouli; Jasper Tromp; Bambang B Siswanto; Michael Zile; John McMurray; Carolyn S P Lam
Journal:  J Am Heart Assoc       Date:  2019-08-21       Impact factor: 5.501

3.  Two-Dimensional and Three-Dimensional Transthoracic Echocardiography as Predictive and Prognostic Indicators of All-Cause Mortality in Heart Failure with Reduced Ejection Fraction in Patients with Ischemic Heart Disease.

Authors:  Aixia Lu; Haibo Fan; Jinfeng Xu; Jun Li; Honglei Zhao
Journal:  Med Sci Monit       Date:  2020-06-07

4.  Clinical evidence and treatment requirements related to heart failure in type 2 diabetes mellitus.

Authors:  Xiao-Ling Cai; Xiang-Qing Wang; Li-Nong Ji
Journal:  Chin Med J (Engl)       Date:  2020-05-20       Impact factor: 2.628

5.  Eligibility of sodium-glucose co-transporter-2 inhibitors among patients with diabetes mellitus admitted for heart failure.

Authors:  Abhinav Sharma; Jingjing Wu; Justin A Ezekowitz; Gary Michael Felker; Jacob A Udell; Paul A Heidenreich; Gregg C Fonarow; Kenneth W Mahaffey; Adrian F Hernandez; Adam D DeVore
Journal:  ESC Heart Fail       Date:  2019-11-20

Review 6.  Highlights in heart failure.

Authors:  Daniela Tomasoni; Marianna Adamo; Carlo Mario Lombardi; Marco Metra
Journal:  ESC Heart Fail       Date:  2019-12

Review 7.  Diabetes mellitus and risk of new-onset and recurrent heart failure: a systematic review and meta-analysis.

Authors:  Satoru Kodama; Kazuya Fujihara; Chika Horikawa; Takaaki Sato; Midori Iwanaga; Takaho Yamada; Kiminori Kato; Kenichi Watanabe; Hitoshi Shimano; Tohru Izumi; Hirohito Sone
Journal:  ESC Heart Fail       Date:  2020-07-29

8.  Ageing, demographics, and heart failure.

Authors:  Andrew J Stewart Coats
Journal:  Eur Heart J Suppl       Date:  2019-12-23       Impact factor: 1.803

9.  Physiological monitoring in the complex multi-morbid heart failure patient - Introduction.

Authors:  Giuseppe M C Rosano; Petar M Seferović
Journal:  Eur Heart J Suppl       Date:  2019-12-31       Impact factor: 1.803

10.  Heart failure management of the elderly patient: focus on frailty, sarcopaenia, cachexia, and dementia: conclusions.

Authors:  Andrew J Stewart Coats
Journal:  Eur Heart J Suppl       Date:  2019-12-23       Impact factor: 1.803

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.